000 01199 a2200325 4500
005 20250517092115.0
264 0 _c20170925
008 201709s 0 0 eng d
022 _a1558-822X
024 7 _a10.1007/s11899-016-0327-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHossain, Nasheed M
245 0 0 _aT-Cell Receptor-Engineered Cells for the Treatment of Hematologic Malignancies.
_h[electronic resource]
260 _bCurrent hematologic malignancy reports
_c08 2016
300 _a311-7 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntigens, Neoplasm
_xgenetics
650 0 4 _aCell Engineering
650 0 4 _aCell- and Tissue-Based Therapy
650 0 4 _aHLA-A2 Antigen
_xmetabolism
650 0 4 _aHematologic Neoplasms
_ximmunology
650 0 4 _aHumans
650 0 4 _aImmunotherapy, Adoptive
650 0 4 _aMembrane Proteins
_xgenetics
650 0 4 _aReceptors, Antigen, T-Cell
_xgenetics
700 1 _aChapuis, Aude G
700 1 _aWalter, Roland B
773 0 _tCurrent hematologic malignancy reports
_gvol. 11
_gno. 4
_gp. 311-7
856 4 0 _uhttps://doi.org/10.1007/s11899-016-0327-0
_zAvailable from publisher's website
999 _c25941300
_d25941300